Reduced P-selectin in Hearts Pretreated with Fluvastatin: A Novel Benefit for Patients Undergoing Open Heart Surgery


Berkan O., Katrancioglu N., Ozker E., Ozerdem G., Bakici Z., Yilmaz M. B.

THORACIC AND CARDIOVASCULAR SURGEON, cilt.57, sa.2, ss.91-95, 2009 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 57 Sayı: 2
  • Basım Tarihi: 2009
  • Doi Numarası: 10.1055/s-2008-1039107
  • Dergi Adı: THORACIC AND CARDIOVASCULAR SURGEON
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.91-95
  • Sivas Cumhuriyet Üniversitesi Adresli: Evet

Özet

Objective: P-selectin is an adhesion molecule that plays a role in the pathogenesis of atherosclerosis. The aim of this study was to assess whether or not the treatment with fluvastatin for 3 weeks preoperatively would reduce the levels of circulating P-selectin in patients with coronary heart disease undergoing coronary artery bypass grafting Surgery (CABG).